key papersKey paper
Japanese gastric cancer treatment guidelines 2021 (6th edition)
The Japanese Gastric Cancer Association guideline sets the criteria for endoscopic resection, the extent of gastrectomy and lymph node dissection, adjuvant chemotherapy by stage and systemic therapy for advanced disease, and is the reference for early gastric cancer worldwide.
Overview
Sixth edition of the Japanese guideline covering absolute and expanded indications for endoscopic submucosal dissection, eCura assessment of curability, surgical procedures and D1+ or D2 lymphadenectomy, laparoscopic and robotic surgery, adjuvant S-1-based chemotherapy, perioperative therapy, and first- to third-line systemic therapy for unresectable disease.
GuidelineChanged practice
Authors
Japanese Gastric Cancer Association.
Published
Gastric cancer, 2023
What it means
The early gastric cancer page's endoscopic criteria and surgical recommendations follow this guideline.
Caveats
- Adjuvant and advanced-disease recommendations reflect Japanese practice (S-1) and differ from Western guidelines.